Table 2. Oxylipin concentrations and immunostaining data from 1) Healthy controls 2) Healthy individuals following subway air exposure 3) Asthmatic controls and 4) Asthmatics following subway air exposure.
Healthy (H) | Asthmatics (A) | p-valuesb | |||||||||||
Control (C) | Subway (S) | Control (C) | Subway (S) | Control | Subway | Healthy | Asthmatics | ||||||
PUFA | Oxylipina (pM) | Average | CV(%)c | Average | CV(%) | Average | CV(%) | Average | CV(%) | H vs A | H vs A | C vs S | C vs S |
AAd | 5-HETE | 199 | 52 | 170 | 44 | 306 | 107 | 240 | 84 | 0.2 | 0.2 | 0.3 | 0.4 |
12-HETE | 64 | 95 | 78 | 109 | 128 | 57 | 129 | 153 | 0.01 | 0.4 | 0.6 | 1.0 | |
15-HETE | 672 | 129 | 666 | 83 | 1363 | 77 | 1089 | 99 | 0.04 | 0.2 | 1.0 | 0.3 | |
15-KETE | 142 | 108 | 126 | 57 | 227 | 67 | 185 | 69 | 0.1 | 0.1 | 0.6 | 0.1 | |
LTB4 | 8 | 49 | 7 | 47 | 12 | 101 | 11 | 80 | 0.2 | 0.1 | 0.6 | 0.7 | |
6-trans-LTB4 | 47 | 55 | 39 | 56 | 44 | 92 | 38 | 86 | 0.8 | 0.9 | 0.2 | 0.5 | |
TXB2 | 64 | 43 | 60 | 42 | 66 | 54 | 63 | 67 | 0.9 | 0.8 | 0.5 | 0.7 | |
PGD2 | 15 | 96 | 15 | 68 | 32 | 108 | 39 | 148 | 0.1 | 0.1 | 0.9 | 0.6 | |
PGE2 | 10 | 48 | 13 | 87 | 15 | 50 | 11 | 89 | 0.04 | 0.7 | 0.4 | 0.1 | |
5(6)-EET | 8 | 70 | 7 | 48 | 8 | 71 | 5 | 34 | 0.8 | 0.1 | 0.5 | 0.2 | |
8(9)-EET | 7 | 72 | 4 | 58 | 7 | 46 | 6 | 59 | 0.7 | 0.1 | 0.04 | 0.3 | |
LAe | 9-HODE | 202 | 103 | 423 | 138 | 188 | 49 | 128 | 44 | 0.8 | 0.05 | 0.04 | 0.02 |
9-KODE | 182 | 100 | 309 | 143 | 66 | 89 | 48 | 50 | 0.02 | 0.02 | 0.1 | 0.3 | |
13-HODE | 1016 | 97 | 1458 | 111 | 1646 | 62 | 1151 | 85 | 0.1 | 0.5 | 0.2 | 0.1 | |
13-KODE | 361 | 82 | 580 | 107 | 234 | 55 | 179 | 54 | 0.1 | 0.01 | 0.1 | 0.1 | |
EKODE | 495 | 89 | 705 | 113 | 189 | 50 | 155 | 45 | 0.01 | 0.01 | 0.1 | 0.3 | |
9,10,13-TriHOME | 262 | 58 | 312 | 81 | 193 | 66 | 116 | 47 | 0.2 | 0.005 | 0.4 | 0.1 | |
9,12,13-TriHOME | 446 | 61 | 543 | 93 | 446 | 59 | 267 | 55 | 1.0 | 0.04 | 0.4 | 0.04 | |
9,10-DiHOME | 408 | 38 | 448 | 44 | 310 | 51 | 267 | 77 | 0.1 | 0.01 | 0.3 | 0.3 | |
9(10)-EpOME | 1877 | 28 | 1829 | 31 | 2012 | 48 | 2083 | 56 | 0.6 | 0.4 | 0.6 | 0.9 | |
12,13-DiHOME | 476 | 41 | 517 | 50 | 373 | 53 | 322 | 75 | 0.1 | 0.03 | 0.3 | 0.3 | |
12(13)-EpOME | 1938 | 27 | 1876 | 33 | 1976 | 44 | 2058 | 53 | 0.9 | 0.6 | 0.6 | 0.8 | |
α-LAf | 9-HOTE | 9 | 129 | 20 | 161 | 11 | 48 | 9 | 55 | 0.5 | 0.2 | 0.1 | 0.1 |
13-HOTE | 52 | 100 | 72 | 116 | 91 | 62 | 71 | 100 | 0.04 | 1.0 | 0.2 | 0.3 | |
EPAg | 12-HEPE | 9 | 101 | 13 | 67 | 16 | 99 | 11 | 108 | 0.1 | 0.6 | 0.1 | 0.4 |
15-HEPE | 64 | 132 | 68 | 74 | 125 | 89 | 93 | 84 | 0.1 | 0.3 | 0.9 | 0.2 | |
DGLAh | 15-HETrE | 63 | 142 | 81 | 174 | 149 | 92 | 118 | 113 | 0.03 | 0.4 | 0.7 | 0.3 |
DHAi | 17-HDoHE | 278 | 137 | 301 | 95 | 461 | 72 | 379 | 93 | 0.2 | 0.5 | 0.9 | 0.4 |
ICCj | 15-LOX-1 | 0.79 | 97 | 0.69 | 126 | 0.80 | 103 | 0.67 | 80 | 0.78 | 0.41 | 0.54 | 0.71 |
COX-1 | 1.64 | 47 | 1.38 | 59 | 1.05 | 69 | 1.19 | 37 | 0.03 | 0.82 | 0.31 | 0.32 | |
COX-2 | 1.92 | 40 | 1.96 | 37 | 1.79 | 47 | 1.70 | 51 | 0.65 | 0.23 | 0.96 | 0.46 | |
PPARγ | 0.55 | 43 | 0.73 | 89 | 0.60 | 54 | 0.55 | 63 | 0.93 | 0.29 | 0.80 | 0.41 |
Oxylipin levels were normalized to the BAL-volume recoveries as described in Table S2 and Table S4,
p-values are based on unpaired for A vs H and paired Student's T-test for C vs S, respectively. Values of p<0.05 are italicized,
Coefficients of variation (%),
Arachidonic acid,
Linoleic acid,
α-Linolenic acid,
Eicosapentaenoic acid,
Dihomo-γ-linolenic acid,
Docosahexaenoic acid,
Immunocytochemistry, RFU values normalized to DAPI intensities.